1 Seheult J, Fitzpatrick G, Boran G: Lactic acidosis: an update. Clin Chem Lab Med 2017;55:322-333.
2 Vincent JL, Quintairos E Silva A, Couto L Jr, Taccone FS: The value of blood lactate kinetics in critically ill patients: a systematic review. Crit Care 2016 ;20:257.
3 Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, Willemsen SP, Bakker J; LACTATE study group: Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010;182:752-761.
4 Nichol AD, Egi M, Pettila V, Bellomo R, French C, Hart G, Davies A, Stachowski E, Reade MC, Bailey M, Cooper DJ: Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care 2010;14:R25.
5 Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801–810.
6 Brickner SJ, Barbachyn MR, Hutchinson DK, Manninen PR: Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. J Med Chem 2008 ;51:1981-1990.
7 Zahedi Bialvaei A, Rahbar M, Yousefi M, Asgharzadeh M, Samadi Kafil H: Linezolid: a promising option in the treatment of Gram-positives. J Antimicrob Chemother 2017;72:354-364.
8 Tang S, Yao L, Hao X, Zhang X, Liu G, Liu X, Wu M, Zen L, Sun H, Liu Y, Gu J, Lin F, Wang X, Zhang Z: Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China. Eur Respir J 2015;45:161-170.
9 Vinh DC, Rubinstein E: Linezolid: a review of safety and tolerability. J Infect 2009;59:S59-74.
10 Kreps EO, Brown L, Rennie IG: Clinical recovery in linezolid-induced optic nerve toxicity. Acta Ophthalmol 2017;95:e341-e342.
11 Narita M, Tsuji BT, Yu VL: Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy 2007;27:1189-1197.
12 Bobylev I, Maru H, Joshi AR, Lehmann HC: Toxicity to sensory neurons and Schwann cells in experimental linezolid-induced peripheral neuropathy. J Antimicrob Chemother 2016;71:685-691.
13 Bressler AM, Zimmer SM, Gilmore JL, Somani J: Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 2004;4:528-531.
14Ferry T, Ponceau B, Simon M, Issartel B, Petiot P, Boibieux A, Biron F, Chidiac C, Peyramond D: Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases. Infection 2005;33:151-154.
15 Hanson BL, Sztern B: Cough and bronchial responsiveness in firefighters at the World Trade Center site. N Engl J Med 2003;348:76-77.
16 Boutoille D, Grossi O, Depatureaux A, Tattevin P: Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosis. Eur J Intern Med 2009;20:e134-135.
17 Beekmann SE, Gilbert DN, Polgreen PM: Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Diagn Microbiol Infect Dis 2008;62:407–410.
18 Garrabou G, Soriano A, López S, Guallar JP, Giralt M, Villarroya F, Martínez JA, Casademont J, Cardellach F, Mensa J, Miró O: Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother 2007;51:962-967.
19 Im JH, Baek JH, Kwon HY, Lee JS: Incidence and risk factors of linezolid-induced lactic acidosis. Int J Infect Dis 2015;31:47-52.
20 Mori N, Kamimura Y, Kimura Y, Hirose S, Aoki Y, Bito S: Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case-control studies of incidenceand associated risk factors. Eur J Clin Pharmacol 2018;74:405-411.
21 Mao Y, Dai D, Jin H, Wang Y: The risk factors of linezolid-induced lactic acidosis: A case report and review. Medicine (Baltimore) 2018;97:e12114.
22 De Vriese AS, Coster RV, Smet J, Seneca S, Lovering A, Van Haute LL, Vanopdenbosch LJ, Martin JJ, Groote CC, Vandecasteele S, Boelaert JR: Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 2006;42:1111-1117.
23 Sawyer AJ, Haley HL, Baty SR, McGuffey GE, Eiland EH: Linezolid-induced lactic acidosis corrected with sustained low-efficiencydialysis: a case report. Am J Kidney Dis 2014;64:457-459.
24 Velez JC, Janech MG: A case of lactic acidosis induced by linezolid.
Nat Rev Nephrol 2010;6:236-242.
25 Contou D, Fichet J, Grimaldi D, Cariou A: Early life-threatening lactic acidosis following a single infusion of linezolid. Int J Antimicrob Agents 2011;38:84-85.
26 Pea F, Scudeller L, Lugano M, Baccarani U, Pavan F, Tavio M, Furlanut M, Rocca GD, Bresadola F, Viale P: Hyperlactacidemia potentially due to linezolid overexposure in a livertransplant recipient. Clin Infect Dis 2006;42:434-435.
27 Su E, Crowley K, Carcillo JA, Michaels MG: Linezolid and lactic acidosis: a role for lactate monitoring with long-termlinezolid use in children. Pediatr Infect Dis J 2011;30:804-806.
28 Protti A, Ronchi D, Bassi G, Fortunato F, Bordoni A, Rizzuti T, Fumagalli R: Changes in Whole-Body Oxygen Consumption and Skeletal MuscleMitochondria During Linezolid-Induced Lactic Acidosis. Crit Care Med2016;44:e579-582.
29 Ozkaya-Parlakay A, Kara A, Celik M, Ozsurekci Y, Karadag Oncel E, Ceyhan M, Cengiz AB: Early lactic acidosis associated with linezolid therapy in paediatricpatients. Int J Antimicrob Agents 2014;44:334-336.
30 Del Pozo JL, Fernández-Ros N, Sáez E , Herrero JI , Yuste JR, Banales JM: Linezolid-induced lactic acidosis in two liver transplant patients with the mitochondrial DNA A2706G polymorphism. Antimicrob Agents Chemother 2014;58:4227-4229.
31 Palenzuela L, Hahn NM, Nelson RP Jr, Arno JN, Schobert C, Bethel R, Ostrowski LA, Sharma MR, Datta PP, Agrawal RK, Schwartz JE, Hirano M: Does linezolid cause lactic acidosis by inhibiting mitochondrial proteinsynthesis? Clin Infect Dis 2005;40:e113-116.
32 Santini A, Ronchi D, Garbellini M, Piga D, Protti A: Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes. Expert Opin Drug Saf 2017;16:833-843.